SUMMARY In view of the claim that low 25-hydroxyvitamin D (25-OHD) concentrations may contribute to the pathogenesis of bone disease in patients with 13 thalassaemia major and iron overload, we have assessed the concentrations of 25-OHD, la,25 dihydroxyvitamin D (la,25(0H)2D), parathyroid hormone, and osteocalcin in such patients. 25-OHD concentrations were significantly lower in patients with thalassaemia major and iron overload than in controls and in some patients were subnormal or undectectable. la,25(OH)2D concentrations were, however, normal in all patients and were similar to those in controls. Serum parathyroid hormone and plasma calcium concentrations were also normal and not significantly different from those in controls. Although 25-OHD concentrations increased significantly between January and June, there was no change in la,25(OH)2D concentrations. 25 
Results
Calcium, phosphate, and albumin concentrations were within the normal range in all patients and were not different from those in controls (Table 1) . Serum 25-OHD concentrations of the 15 patients studied in January (mean(SD) 12-6(6-7)nmol/1) were significantly lower than control values (mean(SD) 35(10)nmol/1) ( Table 2) . Ten of 18 patients studied in January had subnormal 25-OHD concentrations. The serum 25-OHD concentration was greater in June than in January in each of the seven patients in whom such paired samples were available. There were no corresponding increases in calcium concentrations (Table 1 ). The concentration of 25-OHD in these patients was also lower than that in controls during the summer, but this difference was not significant. la,25(OH)2D concentrations were in the middle of the normal range of all patients, irrespective of concomitant subnormal or low-normal 25-OHD concentrations. There was no significant change in la,25(OH)2D concentrations between January and June ( Table 2) .
Parathyroid hormone concentrations were within the normal range in all patients; they fell by a small but not significant amount between January and June ( Table 2) . A similar small diminution in parathyroid hormone was also observed in the controls. Parathyroid hormone concentrations in patients with thalassaemia were lower than those in controls in both summer and winter, but this difference was not significant.
Osteocalcin concentrations ranged between 0-3 and 11-7 ng/ml (mean(SD) 5-3(2-2)ng/ml); in one patient it was subnormal (0-3 ng/ml). Osteocalcin concentrations were not related to 25-OHD, la,25(OH)2D, or parathyroid hormone concentrations. These data indicate that calcium homeostasis is normal in patients with thalassaemia major, although the relative lack of sunshine in the UK contributes to diminished vitamin D stores as reflected by low or low-normal 25-OHD concentrations. The deficiency is more pronounced in winter. There is, however, sufficient 25-OHD to provide an adequate substrate for la-hydroxylation by the kidney, and therefore these patients have normal concentrations of la,25(OH)2D, even during the winter months. It is relevant to mention that administration of vitamin D to patients with osteomalacia who have low 25-OHD and la, 25(OH)2D concentrations can restore la,25 (OH)2D concentrations to normal very rapidlyl' and that minute quantities of calciferol are sufficient to generate large quantities of la,25(OH)2D. 25-OHD concentrations in serum are expressed in nmol/l, while those of la,25(OH)2D are expressed in pmol/l. Serum osteocalcin concentrations are thought to be markers for osteoblastic activity." 12 As osteocalcin concentrations were normal in all patients except one it would seem that osteocalcin is not altered in most of these patients. This does not rule out the possibility, however, that the ratio of carboxylated to non-carboxylated osteocalcin may be altered in such patients. We have recently shown that carboxylation of osteocalcin in man is a vitamin K dependent process'3 and that it may be altered in patients with primary biliary cirrhosis.14 Thus these data suggest that vitamin D deficiency probably does not contribute to the skeletal abnormalities observed in most patients with thalassaemia major. These abnormalities are probably due to the pronounced and diffuse extramedullary haemopoiesis and possibly the deposition of iron in skeletal tissue known to occur in this condition.' 5 Whether the deposition of iron actively interferes with ossification is not known. Bone biopsy examinations have shown evidence of abnormal bone formation, but osteomalacia is extremely rare. '5 There are reports, however, of the presence of thickened osteoid seams, without a lining of osteoblasts on these seams, in patients with 3 thalassaemia with severe untreated anaemia. '6 This occurrence was associated with normal serum 25-OHD concentrations. In contrast, in a rare case of 13 thalassaemia without anaemia a high turnover of bone was observed with normal osteoblasts around osteoid seams. 17 Thus anaemia itself may induce changes in the bone. Longstanding thalassaemia is associated with osteopenia and pathological fractures -this could reflect cumulative effects of defective bone formation through various mechanisms.
Another factor contributing to osteopenia and pathological fractures in this condition could be the delay in the onset, or total absence of puberty. 
